Ifp Advisors, Inc Agenus Inc Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$1.12 - $1.88 $560 - $940	500 New	500 $0
Q4 2021 Jan 12, 2022	SELL	$2.92 - $5.74 $2,920 - $5,740	-1,000 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$4.98 - $6.63 $4,980 - $6,630	1,000 New	1,000 $5,000
Q2 2021 Jul 13, 2021	BUY	$2.56 - $5.49 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.69 - $5.25 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$3.17 - $4.49 $209 - $296	-66 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.98 - $5.2 $196 - $343	66 New	66 $0
Q2 2020 Aug 05, 2020	BUY	$2.29 - $4.24 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.92 - $4.39 $0 - $0	0 New	0 $0
Q4 2017 Jan 24, 2018	SELL	$3.26 - $4.78 $3,233 - $4,741	-992 Closed	0 $0
Q4 2016 Jun 03, 2019	BUY	N/A	988 Added 24700.0%	992 $4,000
Q2 2016 Jun 03, 2019	BUY	N/A	4	4 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.